Stalicla
STALICLA is a mission-driven biotech startup.
Stalicla has raised €9.4M across 2 funding rounds from 1 investor, most recently a round in Jun 2025. Based in Geneva, Switzerland; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€9.4M
€9,432,772
Funding rounds
2
Investors
1
distinct backers
Active since
2020-05
latest 2025-06
Funding by year
EUR raised per yearStalicla — funding by year — interactive chart.
Data table
| Stalicla — funding by year | |
|---|---|
| 2020 | €7.3M |
| 2025 | €2.1M |
Signals
High confidenceRaise-next likelihood36
base rate 30% for Other
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood15
base rate 11% (2+ rounds)
- ▲ 9y since founding (typical exit age)
- ▲ Recent equity round, but funding momentum is down (may be rescue financing)
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-06-30 | Other | €2.1M | Addex Therapeutics | View deal → |
| 2020-05-02 | Series A | €7.3M | — | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData